231 related articles for article (PubMed ID: 34978594)
1. Cortical abnormalities of synaptic vesicle protein 2A in focal cortical dysplasia type II identified in vivo with
Tang Y; Yu J; Zhou M; Li J; Long T; Li Y; Feng L; Chen D; Yang Z; Huang Y; Hu S
Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3482-3491. PubMed ID: 34978594
[TBL] [Abstract][Full Text] [Related]
2. [
Xiao L; Yang J; Zhu H; Zhou M; Li J; Liu D; Tang Y; Feng L; Hu S
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1651-1661. PubMed ID: 38182838
[TBL] [Abstract][Full Text] [Related]
3. First-in-Human Evaluation of
Naganawa M; Li S; Nabulsi N; Henry S; Zheng MQ; Pracitto R; Cai Z; Gao H; Kapinos M; Labaree D; Matuskey D; Huang Y; Carson RE
J Nucl Med; 2021 Apr; 62(4):561-567. PubMed ID: 32859701
[TBL] [Abstract][Full Text] [Related]
4.
Xiao L; Zhou M; Tang Y; Hu S
Epilepsia; 2023 Apr; 64(4):e43-e47. PubMed ID: 36745038
[TBL] [Abstract][Full Text] [Related]
5. Localized focal cortical dysplasia type II: seizure freedom with lesionectomy guided by MRI and FDG-PET.
Usui N; Kondo A; Matsuda K; Ogawa H; Nishida T; Tokumoto K; Kawaguchi N; Matsudaira T; Araki Y; Fukuoka M; Omatsu H; Otani H; Yamaguchi T; Imai K; Takahashi Y
J Neurosurg; 2024 Jun; 140(6):1790-1798. PubMed ID: 37948689
[TBL] [Abstract][Full Text] [Related]
6. Assessment of test-retest reproducibility of [
Li S; Naganawa M; Pracitto R; Najafzadeh S; Holden D; Henry S; Matuskey D; Emery PR; Cai Z; Ropchan J; Nabulsi N; Carson RE; Huang Y
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1327-1338. PubMed ID: 33416954
[TBL] [Abstract][Full Text] [Related]
7. 18 F-SynVesT-1 PET in Focal Cortical Dysplasia Type II With Thickening Cortex.
Tang Y; Yu J; Zhou M; Chen C; Hu S
Clin Nucl Med; 2022 Aug; 47(8):741-743. PubMed ID: 35384870
[TBL] [Abstract][Full Text] [Related]
8. A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [
Zheng C; Holden D; Zheng MQ; Pracitto R; Wilcox KC; Lindemann M; Felchner Z; Zhang L; Tong J; Fowles K; Finnema SJ; Nabulsi N; Carson RE; Huang Y; Cai Z
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1482-1496. PubMed ID: 34761284
[TBL] [Abstract][Full Text] [Related]
9. In vivo PET of synaptic density as potential diagnostic marker for cognitive disorders: prospective comparison with current imaging markers for neuronal dysfunction and relation to symptomatology - study protocol.
Vanderlinden G; Carron C; Vandenberghe R; Vandenbulcke M; Van Laere K
BMC Med Imaging; 2024 Feb; 24(1):41. PubMed ID: 38347458
[TBL] [Abstract][Full Text] [Related]
10. [
Tang Y; Xiao L; Deng C; Zhu H; Gao X; Li J; Yang Z; Liu D; Feng L; Hu S
Eur Radiol; 2024 Feb; 34(2):887-898. PubMed ID: 37581655
[TBL] [Abstract][Full Text] [Related]
11. Compatibility of MRI and FDG-PET findings with histopathological results in patients with focal cortical dysplasia.
Halac G; Delil S; Zafer D; Isler C; Uzan M; Comunoglu N; Oz B; Yeni SN; Vatankulu B; Halac M; Ozkara C
Seizure; 2017 Feb; 45():80-86. PubMed ID: 27960132
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of focal cortical dysplasia and mixed neuronal and glial tumors in pediatric epilepsy patients using 18F-FDG and 11C-methionine pet.
Phi JH; Paeng JC; Lee HS; Wang KC; Cho BK; Lee JY; Park SH; Lee J; Lee DS; Kim SK
J Nucl Med; 2010 May; 51(5):728-34. PubMed ID: 20395328
[TBL] [Abstract][Full Text] [Related]
13. Hypometabolic patterns are related to post-surgical seizure outcomes in focal cortical dysplasia: A semi-quantitative study.
Yao Y; Wang X; Zhao B; Mo J; Guo Z; Yang B; Li Z; Fan X; Cai D; Sang L; Zheng Z; Shao X; Ai L; Hu W; Zhang C; Zhang K
Epilepsia Open; 2024 Apr; 9(2):653-664. PubMed ID: 38265725
[TBL] [Abstract][Full Text] [Related]
14. Focal cortical dysplasia imaging discrepancies between MRI and FDG-PET: Unique association with temporal lobe location.
Yokota H; Uetani H; Tatekawa H; Hagiwara A; Morimoto E; Linetsky M; Yoo B; Ellingson BM; Salamon N
Seizure; 2020 Oct; 81():180-185. PubMed ID: 32847766
[TBL] [Abstract][Full Text] [Related]
15. Focal cortical dysplasia: comparison of MRI and FDG-PET.
Kim SK; Na DG; Byun HS; Kim SE; Suh YL; Choi JY; Yoon HK; Han BK
J Comput Assist Tomogr; 2000; 24(2):296-302. PubMed ID: 10752897
[TBL] [Abstract][Full Text] [Related]
16. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [
Finnema SJ; Toyonaga T; Detyniecki K; Chen MK; Dias M; Wang Q; Lin SF; Naganawa M; Gallezot JD; Lu Y; Nabulsi NB; Huang Y; Spencer DD; Carson RE
Epilepsia; 2020 Oct; 61(10):2183-2193. PubMed ID: 32944949
[TBL] [Abstract][Full Text] [Related]
17. Generation of synthetic PET images of synaptic density and amyloid from
Wang R; Liu H; Toyonaga T; Shi L; Wu J; Onofrey JA; Tsai YJ; Naganawa M; Ma T; Liu Y; Chen MK; Mecca AP; O'Dell RS; van Dyck CH; Carson RE; Liu C
Med Phys; 2021 Sep; 48(9):5115-5129. PubMed ID: 34224153
[TBL] [Abstract][Full Text] [Related]
18. Synaptic density in aging mice measured by [
Xiong M; Roshanbin S; Sehlin D; Hansen HD; Knudsen GM; Rokka J; Eriksson J; Syvänen S
Neuroimage; 2023 Aug; 277():120230. PubMed ID: 37355199
[TBL] [Abstract][Full Text] [Related]
19. Anatomy-based reconstruction of FDG-PET images with implicit partial volume correction improves detection of hypometabolic regions in patients with epilepsy due to focal cortical dysplasia diagnosed on MRI.
Goffin K; Van Paesschen W; Dupont P; Baete K; Palmini A; Nuyts J; Van Laere K
Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1148-55. PubMed ID: 20306037
[TBL] [Abstract][Full Text] [Related]
20. Quantification of SV2A Binding in Rodent Brain Using [
Sadasivam P; Fang XT; Toyonaga T; Lee S; Xu Y; Zheng MQ; Spurrier J; Huang Y; Strittmatter SM; Carson RE; Cai Z
Mol Imaging Biol; 2021 Jun; 23(3):372-381. PubMed ID: 33258040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
